ADAR1 Capital Management »

Anaptysbio Inc Common shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Anaptysbio Inc Common (ANAB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Anaptysbio Inc Common

Tip: Access up to 7 years of quarterly data

All positions including Anaptysbio Inc Common held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anaptysbio Inc Common by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $68k 3.0k 22.52

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Anaptysbio Inc Common

EcoR1 Capital
Frazier Life Sciences Management
BlackRock
BlackRock
Vanguard Group
Tang Capital Management
Boxer Capital
State Street Corporation
First Light Asset Management
T. Rowe Price Associates
Palo Alto Investors
Ikarian Capital
Assenagon Asset Management
Geode Capital Management
Woodline Partners

View all funds holding Anaptysbio Inc Common